Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India flag India · Delayed Price · Currency is INR
1,972.00
-38.20 (-1.90%)
Sep 30, 2025, 3:29 PM IST

Caplin Point Laboratories Company Description

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India.

The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion.

It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags.

Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Caplin Point Laboratories Limited
CountryIndia
Founded1990
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees3,966
CEOSridhar Ganesan

Contact Details

Address:
Ashvich Tower
Chennai, 600096
India
Phone91 44 2496 8000
Websitecaplinpoint.net

Stock Details

Ticker SymbolCAPLIPOINT
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE475E01026
SIC Code2834

Key Executives

NamePosition
Dr. Sridhar GanesanMD and Whole Time Director
D. MuralidharanChief Financial Officer - Finance and Accounts
Partheeban Vivek SiddarthChief Operating Officer - Operations
Venkatram Ganapathisu BramanianGeneral Counsel, Company Secretary and Compliance Officer
Dr. Neelakandan K.President - API Research & Development - Hyderabad
Anto Vijinth V.Functional Head -HO, Human Resources and Admin
M. Sathya NarayananDeputy Chief Financial Officer
Ashok Gorekey PartheebanHead of Marketing - Latam Business
Sivakumar BalasubramanianPlant Head - Puducherry
Dr. S. GunasakaranPresident of Clinical Research Operations